Anti-Tumor Necrosis Factor-α Induced Systemic Lupus Erythematosus()

Anti-tumor necrosis factor-alpha induced lupus (ATIL) represents a major diagnostic and therapeutic challenge. Most cases of ATIL are caused by infliximab, followed by etanercept and adalimumab. Symptoms can range from common, mild cutaneous lesions to rare, serious pleural or pericardial effusions,...

Descripción completa

Detalles Bibliográficos
Autores principales: Almoallim, Hani, Al-Ghamdi, Yahya, Almaghrabi, Haneen, Alyasi, Omnia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Open 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3504723/
https://www.ncbi.nlm.nih.gov/pubmed/23198006
http://dx.doi.org/10.2174/1874312901206010315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3504723/
https://www.ncbi.nlm.nih.gov/pubmed/23198006
http://dx.doi.org/10.2174/1874312901206010315

Ejemplares similares